Dapagliflozin vs Empagliflozin on Flow Mediated Dilation in Type 2 Diabetes Mellitus
Clinical trial NCT04195243 · UNKNOWN
Trial details
- NCT number
- NCT04195243
- Sponsor
- Centro Universitario de Ciencias de la Salud, Mexico
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-02
- Primary completion
- 2020-06-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.